UTIGARD KONSULTING AS
Operating
Drive konsulentvirksomhet innen produktutvikling og produksjon av
biocider, medisinsk utstyr og legemidler.
Keywords
laboratory equipmentlaboratory furnituresurgicalmedicalinstrumentssurgical equipmentdental technologyequipmentorthodonticgoodsdental prosthesesorthodontic appliancestooth fillingsdental cementsadhesivesdental waxplaster preparationslaboratory ovensultrasonic cleaning machineslaboratory sterilization equipmentsyringesneedlescathetersdental chairsartificial teethbridgeshearing aidsglass eyesthermometersvision aidsglasseslensescontact lenses and gogglescardiac pacemakerslaboratory distillation apparatuslaboratory centrifuges
Organization
- CEO
- GU
Geir Utigard1974
- Chairman of the board
- GU
Geir Utigard1974
- Years since formation
- 6 years
- since Apr 15, 2020
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 30
- 1 share class
- Total number of shareholders
- 1
- person
Financials
- Total operating income 2025
- 95,778
- NOK
- Annual total result 2025
- -88,245
- NOK
- Total equity 2025
- 755
- NOK
Last update: Feb 24, 2026
Locations
- Company addressEnsjøsvingen 6B 0661 OSLO, NorgeCopied!
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
GU 1974 | Managing Director/CEO | 100 % directly |
Board
| Name | Role | Shares |
|---|---|---|
GU 1974 | Chairman | 100 % directly |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
GU 1974 | Managing Director/CEO, Chairman | 100 % directly |
Last update: Apr 13, 2023
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
GU 1974 | Ordinary shares | 30 | 100 % |
Last update: Jun 2, 2025
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Total operating income | 95,778 | 266,688 | 253,320 | 1,421,865 |
Annual Total Result | -88,245 | -181,544 | -80,951 | 327,067 |
Total assets | 22,503 | 355,675 | 312,918 | 742,135 |
Total liabilities | 21,748 | 266,674 | 42,373 | 390,640 |
Total equity | 755 | 89,001 | 270,545 | 351,495 |
P&L
| Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Total operating income | 95,778 | 266,688 | 253,320 | 1,421,865 |
Total operating costs | 184,065 | 448,347 | 333,556 | 1,004,204 |
Operating result | -88,287 | -181,659 | -80,236 | 417,661 |
Financial income/costs | 42 | 115 | -715 | 84 |
Profit before tax | -88,245 | -181,544 | -80,951 | 417,745 |
Total tax & extraordinary income/cost | 0 | 0 | 0 | 90,678 |
Annual Total Result | -88,245 | -181,544 | -80,951 | 327,067 |
Balance overview
| Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Total fixed assets | 0 | 0 | 0 | 0 |
Total current assets | 22,503 | 355,675 | 312,918 | 742,135 |
Total assets | 22,503 | 355,675 | 312,918 | 742,135 |
Short term debt | 21,748 | 266,674 | 42,373 | 390,640 |
Long term debt | 0 | 0 | 0 | 0 |
Total liabilities | 21,748 | 266,674 | 42,373 | 390,640 |
Contributed capital | 30,000 | 30,000 | 30,000 | 30,000 |
Retained earnings | -29,245 | 59,001 | 240,545 | 321,495 |
Total equity | 755 | 89,001 | 270,545 | 351,495 |
Total equity and liabilities | 22,503 | 355,675 | 312,918 | 742,135 |
Classification
21st company classification
BETA
Small company
Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
C
Main industrial area
Manufacturing
32
Activity
Other manufacturing
32.5
Main industrial group
Manufacture of medical and dental instruments and supplies
32.50
Industrial group
Manufacture of medical and dental instruments and supplies
32.500
Industrial group
Manufacture of medical and dental instruments and supplies